metabolic syndrome were formulated in time, deriving from the wish of including all its components . (2) The therapeutic success of the patient with metabolic syndrome requires a multidisciplinary approach to lifestyle changes, weight loss, continuous and dynamic dietary i m p ro v e m e n t , s e d e n t a r y re d u c t i o n , normalization of blood pressure, glycemia and lipid parameters . To maintain the values (3) within the optimal parameter range, the patients need to be included in the All data were processed statistically in SPSS version 18 and Excel.
Results and discussions
The inclusion criteria allowed the study of prevalence of metabolic syndrome; the number of diagnosed patients was 1064, representing 22.64% of the total observation sheets studied ( Statistical analysis showed a statistically significant difference (p<0.01) between the patients diagnosed with metabolic syndrome and the total of observation sheets that were (Fig. 3) . 
Current data reveal the presence of inflammatory syndrome within the metabolic syndrome. A faithful marker is C reactive protein (CRP) . In our study, most patients (10, 11) with inflammatory syndrome were included in the group without metabolic syndrome and the group with metabolic syndrome (Group 1) (p<0.001) (Fig. 5 ). Recent studies demonstrate that smoking is associated with an increased risk of developing metabolic syndrome in both women and men . Recent (12) data sustain that patients who gave up smoking and followed a nicotine replacement therapy for 3 months had higher values of systolic blood pressure, basal glycemia, but also an increase of body fat . (13) As metabolic syndrome causes an important heart impairment, we have calculated the percentage of patients who also have coronary heart disease. Thus the presence of coronary heart disease was noted in 36.5% 
